Cite Filings / PLX / 0001558370-23-000003

Feed Companies Filings Check

Sign in

8-K

Current Report

Protalix BioTherapeutics, Inc. Filed 2023-01-03 Acc 0001558370-23-000003

Regulation FD disclosure

Item 7.01 Regulation FD disclosure

From the SEC's structured data for this filing

Documents 1

8-K Current Report , plx-20230103x8k.htm

Around this filing

2023-02-24 8-K Other events
2023-01-05 4 Director bought 110,000 shares at $1.42 ($155,815)
2023-01-03 8-K Regulation FD disclosure
2023-01-03 SC 13G/A Amended Statement of Ownership
2022-12-27 8-K Other events

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)
SEC Structured Data (opens in new tab)

Loading plx-20230103x8k.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…